ozempic or semaglutide vs. Wegovy vs. Mounjaro: What's the Difference? Ozempic® (semaglutide) injection 0.5 mg,

Glucagon-like peptide-1 (GLP-1) receptor agonists, FDA-approved medications for type 2 diabetes and obesity, are increasingly recognized for potential anti-inflammatory properties beyond their metabolic effects

Continue to focus on: Balanced nutrition with emphasis on whole foods and appropriate portion sizes Regular physical activity appropriate to your fitness level and medical clearance Adequate hydration to support overall health and potentially reduce side effects Sleep hygiene as quality rest supports metabolic health and weight management Monitoring and Support Regular follow-up with your GP or prescribing clinician is essential during the transition period

Foam cell formation during atherogenesis could be also explained in part by uptake of CRP-opsonized native LDL (193)

Photographic Documentation Protocol Not required unless injection site reaction occurs

Your provider monitors your progress and adjusts your plan as needed